Venous thromboembolism (VTE) in Europe
Venous thromboembolism (VTE) is often asymptomatic, misdiagnosed, and unrecognized at
death, and there is a lack of routine postmortem examinations. These factors are thought to …
death, and there is a lack of routine postmortem examinations. These factors are thought to …
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study
Objectives: This trial sought to assess the influence of omeprazole on clopidogrel efficacy.
Background: Clopidogrel has proved its benefit in the treatment of atherothrombotic …
Background: Clopidogrel has proved its benefit in the treatment of atherothrombotic …
High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patients
E Oger, L Bressollette, M Nonent… - Thrombosis and …, 2002 - thieme-connect.com
The prevention of venous thromboembolism in medical patients remains questioned. All
consecutive outpatients admitted in our medical unit were considered for inclusion in this …
consecutive outpatients admitted in our medical unit were considered for inclusion in this …
[HTML][HTML] A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism
G Simonneau, H Sors, B Charbonnier… - … England Journal of …, 1997 - Mass Medical Soc
Background Low-molecular-weight heparin appears to be at least as effective and safe as
standard, unfractionated heparin for the treatment of deep-vein thrombosis, but only limited …
standard, unfractionated heparin for the treatment of deep-vein thrombosis, but only limited …
Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial
Summary Background Multislice CT (MSCT) combined with D-dimer measurement can
safely exclude pulmonary embolism in patients with a low or intermediate clinical probability …
safely exclude pulmonary embolism in patients with a low or intermediate clinical probability …
Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: the PADIS-PE randomized clinical trial
F Couturaud, O Sanchez, G Pernod, P Mismetti, P Jego… - Jama, 2015 - jamanetwork.com
Importance The optimal duration of anticoagulation after a first episode of unprovoked
pulmonary embolism is uncertain. Objectives To determine the benefits and harms of an …
pulmonary embolism is uncertain. Objectives To determine the benefits and harms of an …
Prevention of venous thrombosis in patients with acute intracerebral hemorrhage
K Lacut, L Bressollette, G Le Gal, E Etienne… - Neurology, 2005 - AAN Enterprises
Objective: To assess intermittent pneumatic compression (IPC) in the prevention of venous
thromboembolism (VTE). Methods: The authors randomly allocated patients with a …
thromboembolism (VTE). Methods: The authors randomly allocated patients with a …
Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial
E Oger, M Alhenc-Gelas, K Lacut… - … , and vascular biology, 2003 - Am Heart Assoc
Objective—Activated protein C (APC) resistance not related to the factor V Leiden mutation
is a risk factor for venous thrombosis. Oral estrogen replacement therapy (ERT) has been …
is a risk factor for venous thrombosis. Oral estrogen replacement therapy (ERT) has been …
Modulating innate and adaptive immunity by (R)-roscovitine: potential therapeutic opportunity in cystic fibrosis
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity
in Cystic Fibrosis | Journal of Innate Immunity | Karger Publishers Skip to Main Content S …
in Cystic Fibrosis | Journal of Innate Immunity | Karger Publishers Skip to Main Content S …
Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial
E Pasquier, L de Saint Martin, C Bohec… - Blood, The Journal …, 2015 - ashpublications.org
It is common practice in many centers to offer antithrombotic medications to women with
unexplained recurrent miscarriage, in the presence or absence of inherited thrombophilia …
unexplained recurrent miscarriage, in the presence or absence of inherited thrombophilia …